Vildagliptin 50mg + Metformin 1000mg film-coated tablets combine two powerful antidiabetic agents to help manage type 2 diabetes mellitus effectively. Vildagliptin, a DPP-4 inhibitor, enhances incretin levels, improving insulin secretion and reducing glucagon release, while Metformin, a biguanide, decreases hepatic glucose production and improves insulin sensitivity. Together, they help maintain blood sugar levels within the normal range, reduce post-meal glucose spikes, and support long-term glycemic control. This combination is particularly suitable for patients who require dual-action therapy to achieve optimal blood sugar management.
